%0 Journal Article
%A Schlenk, Richard
%T Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemia.
%J Haematologica
%V 109
%N 6
%@ 0390-6078
%C Pavia
%I Ferrata Storti Foundation
%M DKFZ-2024-01192
%P 1629 - 1630
%D 2024
%Z #LA:W010# / Haematologica |  LANDMARK PAPER IN HEMATOLOGY
%K Humans
%K Cytarabine: therapeutic use
%K Cytarabine: administration & dosage
%K Leukemia, Myeloid, Acute: genetics
%K Leukemia, Myeloid, Acute: drug therapy
%K Consolidation Chemotherapy
%K Male
%K Female
%K Middle Aged
%K Antimetabolites, Antineoplastic: therapeutic use
%K Antimetabolites, Antineoplastic: administration & dosage
%K Prognosis
%K Adult
%K Aged
%K Biomarkers, Tumor: genetics
%K Treatment Outcome
%K Cytarabine (NLM Chemicals)
%K Antimetabolites, Antineoplastic (NLM Chemicals)
%K Biomarkers, Tumor (NLM Chemicals)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:38832418
%R 10.3324/haematol.2024.285624
%U https://inrepo02.dkfz.de/record/290595